Evolutionary Genomics, Inc. Cash and Restricted Cash
Evolutionary Genomics, Inc. had Cash and Restricted Cash of $577.07 thousand as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2023-03-09
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $577.07K.
- 2022-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $765.55K.
- 2022-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $897.78K.
- 2022-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.04M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2022-12-31 | $577.07K 10-K · filed 2023-03-09 |
| 2022-09-30 | $765.55K 10-Q · filed 2022-10-21 |
| 2022-06-30 | $897.78K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $1.04M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $214.01K 10-K · filed 2023-03-09 |
| 2021-09-30 | $605.51K 10-Q · filed 2022-10-21 |
| 2021-06-30 | $588.00 10-Q · filed 2022-08-08 |
| 2021-03-31 | $97.56K 10-Q · filed 2022-05-16 |
| 2020-12-31 | $215.84K 10-K · filed 2023-03-09 |
| 2019-12-31 | $45.44K 10-K · filed 2022-03-22 |